Bio-Rad Laboratories Class A
198 hedge funds and large institutions have $2.25B invested in Bio-Rad Laboratories Class A in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 70 increasing their positions, 75 reducing their positions, and 24 closing their positions.
111% more call options, than puts
Call options by funds: $676K | Put options by funds: $321K
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more capital invested
Capital invested by funds: $2.06B → $2.25B (+$190M)
2.52% more ownership
Funds ownership: 74.69% → 77.21% (+2.5%)
7% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 75
2% less funds holding
Funds holding: 203 → 198 (-5)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$37.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.6M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
+$21.6M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$20.6M |
| 5 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Senator Investment Group
New York
|
-$54.2M |
| 2 |
RA
Royce & Associates
New York
|
-$11.8M |
| 3 |
FPA
First Pacific Advisors
El Segundo,
California
|
-$9.19M |
| 4 |
VAM
Visium Asset Management
New York
|
-$8.96M |
| 5 |
LCS
Levin Capital Strategies
New York
|
-$7.47M |
BIO Hedge Fund Activity: Q4 2013 in Review
198 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2013, worth a combined $2.25B — up 9.2% from $2.06B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of BIO and 20 opened new positions — a net loss of 4 holders — while 75 trimmed existing stakes and 70 added.
The largest buyer was NWQ Investment Management Company, adding an estimated $37.7M. The largest seller was Senator Investment Group, cutting an estimated $54.2M.
- 198 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2013, down from 203 in Q3 2013.
- Funds reported $2.25B of Bio-Rad Laboratories Class A stock for Q4 2013, up 9.2% quarter-over-quarter.
- 20 funds opened new Bio-Rad Laboratories Class A positions in Q4 2013 and 24 closed out, a net change of -4 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2013 was NWQ Investment Management Company, an estimated $37.7M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2013 was Senator Investment Group, an estimated $54.2M sold.
Based on aggregated 13F filings for Q4 2013.